“Mucinous” cancers in both cohorts are not always in line with the WHO definition of >50% extracellular mucin, especially in the TCGA cohort, where the median extracellular value is 50% (indicating that half the so-called mucinous cases are below that value). This evidence concerns the gene MUC5AC and cancer.